Empirical Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Buy
13,572
+8,044
+146% +$709K 0.02% 435
2026
Q2
$432K Buy
5,528
+731
+15% +$59K 0.01% 736
2026
Q1
$416K Sell
4,797
-2,033
-30% -$195K 0.01% 651
2025
Q4
$656K Buy
6,830
+1,319
+24% +$128K 0.01% 432
2025
Q3
$525K Buy
5,511
+1,230
+29% +$113K 0.01% 461
2025
Q2
$373K Sell
4,281
-24
-0.6% -$2.04K 0.01% 476
2025
Q1
$387K Sell
4,305
-7,309
-63% -$654K 0.01% 458
2024
Q4
$928K Buy
11,614
+1,955
+20% +$169K 0.03% 286
2024
Q3
$870K Buy
9,659
+718
+8% +$60.4K 0.02% 292
2024
Q2
$704K Buy
8,941
+1,072
+14% +$87.9K 0.02% 294
2024
Q1
$686K Buy
7,869
+2,211
+39% +$189K 0.02% 293
2023
Q4
$466K Sell
5,658
-3,441
-38% -$262K 0.02% 332
2023
Q3
$713K Buy
9,099
+1,651
+22% +$138K 0.03% 261
2023
Q2
$656K Buy
7,448
+1,249
+20% +$108K 0.03% 268
2023
Q1
$500K Buy
6,199
+43
+0.7% +$3.5K 0.02% 321
2022
Q4
$478K Sell
6,156
-937
-13% -$75.9K 0.02% 315
2022
Q3
$573K Sell
7,093
-3,258
-31% -$293K 0.03% 275
2022
Q2
$929K Buy
10,351
+1,296
+14% +$131K 0.05% 206
2022
Q1
$1M Sell
9,055
-1,087
-11% -$115K 0.05% 212
2021
Q4
$1.05M Sell
10,142
-438
-4% -$50.7K 0.05% 209
2021
Q3
$1.33M Sell
10,580
-144
-1% -$18.6K 0.08% 156
2021
Q2
$1.33M Sell
10,724
-615
-5% -$77.2K 0.08% 152
2021
Q1
$1.34M Sell
11,339
-2,278
-17% -$267K 0.11% 128
2020
Q4
$1.6M Buy
13,617
+361
+3% +$39.7K 0.12% 115
2020
Q3
$1.38M Sell
13,256
-440
-3% -$44.2K 0.12% 118
2020
Q2
$1.26M Buy
13,696
+1,690
+14% +$162K 0.12% 115
2020
Q1
$1.08M Buy
12,006
+2,434
+25% +$259K 0.12% 109
2019
Q4
$1.09M Buy
9,572
+7,328
+327% +$804K 0.12% 118
2019
Q3
$244K Buy
2,244
+147
+7% +$15.3K 0.03% 254
2019
Q2
$204K Buy
+2,097
New +$191K 0.03% 249
2015
Q4
– Sell
-4,010
Closed -$268K – 109
2015
Q3
$268K Buy
+4,010
New +$295K 0.06% 100

Other funds holding MDT

Empirical Wealth Management's MDT Position: Q3 2026 in Review

Empirical Wealth Management increased its Medtronic (MDT) stake by 146% in Q3 2026, buying an estimated $709K and bringing the position to 13,572 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #435.

Empirical Wealth Management first reported a position in MDT in Q3 2015 and has held it in 31 quarters since. The position peaked at $1.6M in Q4 2020. 2,197 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Empirical Wealth Management held 13,572 shares of Medtronic worth $1.17M as of Q3 2026.
  • Empirical Wealth Management bought 8,044 Medtronic shares in Q3 2026, an estimated $709K.
  • Medtronic made up 0.02% of Empirical Wealth Management's portfolio in Q3 2026, its #435 holding.
  • Empirical Wealth Management first reported a position in Medtronic in Q3 2015 and has held it in 31 quarters since.
  • Empirical Wealth Management's Medtronic position peaked at $1.6M in Q4 2020.
  • 2,197 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.